$7.51
-0.29-3.66%
Last update: Oct 30, 5:43 PM
Immunic Inc (IMUX) Stock Price, Quote, News & History
IMUXNASDAQ
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis...
You can purchase shares of Immunic (NASDAQ:IMUX) through any online brokerage.
Other companies in Immunic’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Immunic has a consensus price target of $59.89.
The stock price for Immunic (NASDAQ: IMUX) is $7.62 last updated October 30, 2026 at 5:43 PM EDT.
There are no upcoming dividends for Immunic.
Immunic does not have any upcoming earnings scheduled.
There is no upcoming split for Immunic.
Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting...
